PRINCETON, N.J.--(BUSINESS WIRE)--PharmaNet Development Group, Inc. (the “Company”) (NASDAQ: PDGI), a leading provider of global drug development services, announced today that it has appointed Bengt Danielsson, M.D., Ph.D., to the position of Vice President, PharmaNet Consulting. Dr. Danielsson joins the Company from the Swedish Medical Product Agency where he served as Scientific Director/Professor in Pharmacology and Toxicology for the past three years. During that time he also served as a member and the EU Pharmacology & Toxicology representative of the EMEA/CHMP Innovative Medicine Task Force group and a member and Swedish representative of the CHMP/EU Safety and CHMP/EU Cell-based Products working parties.
